Denali Therapeutics Inc. · NASDAQ:DNLI
Baker Brothers Life Sciences LP received 6,408 Denali Therapeutics Inc. shares as an award (Form 4)
Traded Jun 3, 2026 · Filed Jun 5, 2026
On Jun 3, 2026, Baker Brothers Life Sciences LP (Director) received 6,408 Denali Therapeutics Inc. shares as an award, leaving 343,275 shares. Filed Jun 5, 2026 (Form 4).
- Awarded
- 6,408 shares
- Holding after
- 343,275 shares (held indirectly)
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | Common Stock | Award | 6,408 | 343,275 | Indirect |